Skip to content
Home/Companies/Biotech/Entelo Bio
Entelo Bio

Entelo Bio

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Entelo Bio?

Entelo Bio is a German Biotech company, currently owned by Ananda Impact Ventures since 2024.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Ananda Impact Ventures
Investor
Ananda Impact Ventures
Ananda Impact Fund IV · 2022 · Impact

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.entelo.bio

More from Ananda Impact Fund IV

Other portfolio companies in the same fund.

Jua
Active
AI/MLSwitzerland· 2025
Mycolever
Active
IndustrialsGermany· 2025
Nordic Salt Cycle
Active
ClimateTechDenmark· 2025
Pheiron
Pheiron
Active
BiotechGermany· 2025
Pulsetrain
Active
MobilityGermany· 2025
Decade
Active
ClimateTechGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Entelo Bio?

Entelo Bio is currently owned by Ananda Impact Ventures, through Ananda Impact Fund IV, since 2024.

When did Ananda Impact Ventures acquire Entelo Bio?

Ananda Impact Ventures acquired Entelo Bio in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue